In 1996, Imperial Professor Steve Bloom discovered a digestive hormone, GLP-1, which plays a crucial role in regulating appetite. In the decades that followed, Steve built on his work, mentoring hundreds of young researchers along the way, and creating two spinouts. 1/2
1
4
11
Now, GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro are transforming obesity treatment. Professor Bloom's group is now part of a vibrant community at Imperial, working on obesity, diabetes, and a range of conditions where GLP-1 may play a role. Read more ⤵️ imperial.ac.uk/Stories/the-d…

The discovery that launched a new wave of weight loss drugs

Professor Stephen Bloom’s pioneering work on GLP-1 epitomises Imperial’s cross-disciplinary approach to obesity and its impacts

imperial.ac.uk

Nov 7, 2025 · 12:21 PM UTC
6